Galapagos NV

Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress

06 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos receives positive CHMP opinion for Jyseleca® European label update based on testicular function safety data from MANTA/RAy studies

03 окт 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos increases share capital through subscription right exercises

27 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos receives transparency notification from FMR LLC

29 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos to present at upcoming investor conferences

24 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos receives transparency notification from FMR LLC

18 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

First key steps in pipeline rebuild and strong commercial progress in H1 2022

04 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies

21 июн 2022 16:03:08 Источник Nasdaq GlobeNewswire

Galapagos increases share capital through subscription right exercises

20 июн 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos receives transparency notification from FMR LLC

01 июн 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress

25 май 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos creates new subscription right plans

06 май 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos demonstrates regulatory and commercial progress in Q1 2022

05 май 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos announces appointment of Dr. Paul Stoffels as Chairman of the board

26 апр 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos publishes 2021 annual report and announces extraordinary and annual shareholders’ meetings

24 мар 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos increases share capital through subscription right exercises

18 мар 2022 17:01:00 Источник Nasdaq GlobeNewswire

Galapagos 2021 results set stage for future growth

24 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos receives transparency notification from EcoR1 Capital

03 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress

02 фев 2022 16:01:00 Источник Nasdaq GlobeNewswire

Galapagos creates new subscription right plan

26 янв 2022 16:40:00 Источник Nasdaq GlobeNewswire